Llwytho...
Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity
PURPOSE: Anticancer drug delivery systems are often limited by hurdles, such as off-target distribution, slow cellular internalization, limited lysosomal escape, and drug resistance. To overcome these limitations, we have developed a stable nitric oxide (NO)-releasing nanoparticle (polystyrene-malei...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Int J Nanomedicine |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251458/ https://ncbi.nlm.nih.gov/pubmed/30538458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S187089 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|